telogen effluvium glp 1 Hair loss reported during GLP-1 therapy is most commonly explained by effluvium, a delayed response to rapid weight loss and undernutrition., ‌, Two key contributors I assess clinically:, GLP-1 Inhibitors and Hairloss —

Each treatment plan is tailored to restore harmony without overfilling or exaggerating features

Heart Health : Reduces the risk of major cardiovascular events, such as heart attacks and strokes

Here's what that means for your plate: the foods that support that same process fiber, lean protein, healthy fats become your strongest allies

If GLP-1s arent an option, there are still effective paths forward

The dosing protocols differ significantly between the two medications, with tirzepatide starting at 2.5 mg weekly and potentially escalating to 15 mg based on tolerance and response

EST), email at [email protected], and or use in-portal messaging